Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by JDavenporton Nov 16, 2022 4:50pm
117 Views
Post# 35104795

RE:RE:RE:RE:RE:RE:RE:RE:Grow up and move on please...

RE:RE:RE:RE:RE:RE:RE:RE:Grow up and move on please...I won't be writing the story of Bioasis, Comonreally42, but the situation and the people can form part of a larger fiction.

You know what they say. Write what you know. Therefore, we have no reason to expect writings from you.

So, if Bioasis cannot be sold, and if it cannot attract deals, then would you describe to us what the problem with xB3 is, please?

jd

<< Previous
Bullboard Posts
Next >>